Temporal Changes in Microrna Expression in Blood Leukocytes from Patients with the Acute Respiratory Distress Syndrome

Overview

Journal Shock

Date 2016 Nov 24

PMID 27879560

Citations 10

Authors

Purushottam Narute

Nitin Seam

Margaret Tropea

Carolea Logun

Rongman Cai

Junfeng Sun

James H Shelhamer

Gianfranco U Meduri

Anthony F Suffredini

Affiliations

Soon will be listed here.

Abstract

Background: MicroRNA (miRNA) control gene transcription by binding to and repressing the translation of messenger RNA (mRNA). Their role in the acute respiratory distress syndrome (ARDS) is undefined.

Methods: Blood leukocytes from 51 patients enrolled in a prior randomized trial of corticosteroids for ARDS were analyzed. After screening eight patients with microarrays for altered miRNA expression, 25 miRNAs were selected for further analysis using RT-PCR in all 51 patients.

Results: On day 0, the 51 patients had APACHE III score of 60.4 ± 17.7 and PaO2/FiO2 of 117 ± 49. 21 miRNA were expressed at increased levels in blood leukocytes at the onset of ARDS compared with healthy controls. These miRNA remained elevated at day 3 and increased further by day 7 (log2 fold change from 0.66 to 5.7 fold, P <0.05 compared to day 0). In a subgroup analysis (37 patients treated with corticosteroids and 14 treated with placebo), the interaction of miRNA expression over time and steroid administration was not significant suggesting that systemic corticosteroids had no effect on the miRNA detected in our study. In contrast, corticosteroids but not placebo decreased IL-6 and C-reactive protein at day 3 (P < 0.001) demonstrating an early systemic anti-inflammatory response whereas both treatment arms had decreased values by day 7 (P <0.001).

Conclusions: Expression of miRNA is increased in blood leukocytes of patients with ARDS at day 0 and day 3 and rises further by day 7, when systemic inflammation is subsiding. These effects appear independent of the administration of steroids, suggesting different inflammatory modifying roles for each in the resolving phases of ARDS.

Citing Articles

Personalized medicine using omics approaches in acute respiratory distress syndrome to identify biological phenotypes.

Battaglini D, Al-Husinat L, Normando A, Leme A, Franchini K, Morales M Respir Res. 2022; 23(1):318.

PMID: 36403043 PMC: 9675217. DOI: 10.1186/s12931-022-02233-0.

Prognostic value of pulmonary ultrasound score combined with plasma miR-21-3p expression in patients with acute lung injury.

Liu R, Zhao G, Wang Q, Gong F J Clin Lab Anal. 2022; 36(3):e24275.

PMID: 35141939 PMC: 8906047. DOI: 10.1002/jcla.24275.

A novel miRNA biomarker panel associated with mortality in pediatric patients with ARDS.

Lee L, Eghbali M, Sapru A Respir Res. 2021; 22(1):169.

PMID: 34088312 PMC: 8177032. DOI: 10.1186/s12931-021-01761-5.

Identification of a Circulating miRNA Signature to Stratify Acute Respiratory Distress Syndrome Patients.

Martucci G, Arcadipane A, Tuzzolino F, Occhipinti G, Panarello G, Carcione C J Pers Med. 2020; 11(1).

PMID: 33375484 PMC: 7824233. DOI: 10.3390/jpm11010015.

The Role of MicroRNAs in Acute Respiratory Distress Syndrome and Sepsis, From Targets to Therapies: A Narrative Review.

Lee L, Medzikovic L, Eghbali M, Eltzschig H, Yuan X Anesth Analg. 2020; 131(5):1471-1484.

PMID: 33079870 PMC: 8532045. DOI: 10.1213/ANE.0000000000005146.

References

Mendell J, Olson E . MicroRNAs in stress signaling and human disease. Cell. 2012; 148(6):1172-87. PMC: 3308137. DOI: 10.1016/j.cell.2012.02.005. View

Tessel M, Benham A, Krett N, Rosen S, Gunaratne P . Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma. Horm Cancer. 2011; 2(3):182-9. PMC: 3725966. DOI: 10.1007/s12672-011-0072-8. View

Guo L, Xu J, Qi J, Zhang L, Wang J, Liang J . MicroRNA-17-92a upregulation by estrogen leads to Bim targeting and inhibition of osteoblast apoptosis. J Cell Sci. 2012; 126(Pt 4):978-88. DOI: 10.1242/jcs.117515. View

Han S, Mallampalli R . The acute respiratory distress syndrome: from mechanism to translation. J Immunol. 2015; 194(3):855-60. PMC: 4299926. DOI: 10.4049/jimmunol.1402513. View

Moschos S, Williams A, Perry M, Birrell M, Belvisi M, Lindsay M . Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics. 2007; 8:240. PMC: 1940008. DOI: 10.1186/1471-2164-8-240. View

Rajasekaran S, Pattarayan D, Rajaguru P, Sudhakar Gandhi P, Thimmulappa R . MicroRNA Regulation of Acute Lung Injury and Acute Respiratory Distress Syndrome. J Cell Physiol. 2016; 231(10):2097-106. DOI: 10.1002/jcp.25316. View

Yang Z, Wang L . Regulation of microRNA expression and function by nuclear receptor signaling. Cell Biosci. 2011; 1(1):31. PMC: 3192659. DOI: 10.1186/2045-3701-1-31. View

Mukherji S, Ebert M, Zheng G, Tsang J, Sharp P, van Oudenaarden A . MicroRNAs can generate thresholds in target gene expression. Nat Genet. 2011; 43(9):854-9. PMC: 3163764. DOI: 10.1038/ng.905. View

Becker N, Lockwood C . Pre-analytical variables in miRNA analysis. Clin Biochem. 2013; 46(10-11):861-8. DOI: 10.1016/j.clinbiochem.2013.02.015. View

10.

Ha M, Kim V . Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014; 15(8):509-24. DOI: 10.1038/nrm3838. View

11.

Seam N, Meduri G, Wang H, Nylen E, Sun J, Schultz M . Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome. Crit Care Med. 2011; 40(2):495-501. PMC: 10802149. DOI: 10.1097/CCM.0b013e318232da5e. View

12.

Smyth G . Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2006; 3:Article3. DOI: 10.2202/1544-6115.1027. View

13.

Jung M, Schaefer A, Steiner I, Kempkensteffen C, Stephan C, Erbersdobler A . Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clin Chem. 2010; 56(6):998-1006. DOI: 10.1373/clinchem.2009.141580. View

14.

Meduri G, Golden E, Freire A, Taylor E, Zaman M, Carson S . Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007; 131(4):954-63. DOI: 10.1378/chest.06-2100. View

15.

Kovach M, Stringer K, Bunting R, Wu X, San Mateo L, Newstead M . Microarray analysis identifies IL-1 receptor type 2 as a novel candidate biomarker in patients with acute respiratory distress syndrome. Respir Res. 2015; 16:29. PMC: 4339297. DOI: 10.1186/s12931-015-0190-x. View

16.

Foster P, Plank M, Collison A, Tay H, Kaiko G, Li J . The emerging role of microRNAs in regulating immune and inflammatory responses in the lung. Immunol Rev. 2013; 253(1):198-215. DOI: 10.1111/imr.12058. View

17.

Harada M, Pokrovskaja-Tamm K, Soderhall S, Heyman M, Grander D, Corcoran M . Involvement of miR17 pathway in glucocorticoid-induced cell death in pediatric acute lymphoblastic leukemia. Leuk Lymphoma. 2012; 53(10):2041-50. DOI: 10.3109/10428194.2012.678004. View

18.

Meduri G, Bridges L, Shih M, Marik P, Siemieniuk R, Kocak M . Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. 2015; 42(5):829-840. DOI: 10.1007/s00134-015-4095-4. View

19.

Concepcion C, Bonetti C, Ventura A . The microRNA-17-92 family of microRNA clusters in development and disease. Cancer J. 2012; 18(3):262-7. PMC: 3592780. DOI: 10.1097/PPO.0b013e318258b60a. View

20.

Puimege L, Van Hauwermeiren F, Steeland S, Van Ryckeghem S, Vandewalle J, Lodens S . Glucocorticoid-induced microRNA-511 protects against TNF by down-regulating TNFR1. EMBO Mol Med. 2015; 7(8):1004-17. PMC: 4551340. DOI: 10.15252/emmm.201405010. View